findmyKOL
Clinical trialNCT00004635CompletedPhase 3Interventional

Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

SponsorNational Cancer Institute (NCI)Enrollment159Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • William L Dahut, M.D.

    National Cancer Institute, National Institutes of Heath

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Holy Cross Hospital, Fort Lauderdale

    Fort Lauderdale, Florida, United States

  • Louisiana State University

    New Orleans, Louisiana, United States

  • National Institutes of Health, Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States

  • Wayne State University Hutzel Hospital

    Detroit, Michigan, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Columbia University

    New York, New York, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Naval Medical Center, Portsmouth

    Portsmouth, Virginia, United States

  • University of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Mar 2000
Primary completion
30 Jan 2005
Completion
30 Mar 2010
Last update posted
22 May 2018
Registered enrollment
159
Registry id
NCT00004635

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.